Zoetis Inc. (NYSE:ZTS) Position Cut by Argus Investors Counsel Inc

Xavier Trudeau
Août 13, 2017

Harfst & Associates Inc. boosted its position in Zoetis by 16.1% in the second quarter. (NYSE:ZTS) by 0.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). Morgan Stanley now owns 14,617,205 shares of the company's stock valued at $780,119,000 after buying an additional 9,442,207 shares in the last quarter. Berkshire Asset Management LLC PA's holdings in Zoetis were worth $2,055,000 as of its most recent filing with the SEC.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Guardian Life Insurance Co. of America increased its stake in shares of Zoetis by 0.7% in the first quarter. UBS Asset Management Americas Inc. now owns 1,850,647 shares of the company's stock worth $99,065,000 after buying an additional 13,853 shares in the last quarter. Waddell & Reed Financial Inc. raised its stake in shares of Zoetis by 65.9% in the first quarter. Assetmark Inc. now owns 1,918 shares of the company's stock valued at $102,000 after buying an additional 85 shares during the period. Raymond James Trust N.A. increased its stake in shares of Zoetis by 24.6% in the first quarter. Argent Trust Co now owns 4,132 shares of the company's stock valued at $221,000 after buying an additional 32 shares during the last quarter. Almanack Investment Partners LLC. bought a new position in Zoetis during the second quarter valued at $119,000. Global Financial Private Capital LLC now owns 5,366 shares of the company's stock valued at $335,000 after buying an additional 563 shares during the last quarter. Finally, CENTRAL TRUST Co increased its stake in Zoetis by 1.9% in the first quarter. The fund owned 121,700 shares of the company's stock after selling 100 shares during the period. Zoetis Inc. has a 1-year low of $46.86 and a 1-year high of $63.85. (NYSE ZTS) traded down 0.02% during midday trading on Friday, reaching $59.73. The firm has a market cap of $29.21 billion, a PE ratio of 33.76 and a beta of 1.02. The company's 50-day moving average price is $62.20 and its 200 day moving average price is $58.00.

Zoetis (NYSE:ZTS) last announced its quarterly earnings results on Tuesday, August 8th. The company reported $0.53 earnings per share for the quarter, meeting the consensus estimate of $0.53. Zoetis had a return on equity of 62.49% and a net margin of 17.50%. The firm had revenue of $1.27 billion for the quarter, compared to analyst estimates of $1.27 billion. During the same period in the prior year, the company posted $0.49 EPS. The firm's quarterly revenue was up 5.0% compared to the same quarter previous year. On average, analysts anticipate that Zoetis Inc. will post $2.34 earnings per share for the current fiscal year. If you are viewing this news story on another site, it was illegally copied and republished in violation of worldwide copyright law.

Zoetis Inc. (NYSE:ZTS)'s stock had its "buy" rating reaffirmed by Deutsche Bank AG in a note issued to investors on Monday, July 17th.

TRADEMARK VIOLATION WARNING: This article was originally published by BBNS and is the sole property of of BBNS. If you are accessing this report on another website, it was copied illegally and reposted in violation of US and worldwide copyright & trademark legislation. The original version of this report can be viewed at https://www.chaffeybreeze.com/2017/08/13/zoetis-inc-nysezts-given-a-70-00-price-target-at-cowen-and-company-updated-updated-updated.html.

Several equities research analysts recently issued reports on ZTS shares. Zacks Investment Research raised shares of Zoetis from a "hold" rating to a "buy" rating and set a $67.00 price target for the company in a research report on Wednesday, May 10th. Deutsche Bank AG reiterated a "buy" rating and set a $65.00 price target (up from $62.00) on shares of Zoetis in a research note on Monday, July 17th. Finally, Jefferies Group LLC increased their target price on shares of Zoetis from $65.00 to $70.00 and gave the stock a "buy" rating in a research report on Tuesday, May 9th. Hilliard Lyons began coverage on shares of Zoetis in a research report on Tuesday, June 20th. They issued a "buy" rating and a $71.00 price target for the company. BMO Capital Markets reissued a "buy" rating and issued a $60.00 price objective on shares of Zoetis in a research report on Thursday, May 4th.

D'autres rapports CampDesrEcrues

Discuter de cet article

SUIVRE NOTRE JOURNAL